Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-03-30FDA Approved: ARISTADA — Supplemental Application (Alkermes, Inc.)
The FDA approved a supplemental application for ARISTADA (aripiprazole lauroxil) from Alkermes, Inc., to update the product labeling as requ…
-
FDA approval · 2021-03-30FDA Approved: ARISTADA INITIO — Supplemental Application (Alkermes, Inc.)
FDA approved a supplemental application for Aristada Initio (aripiprazole lauroxil) from Alkermes, adding an initiation option for schizophr…
-
FDA approval · 2021-03-09FDA Approved: ASENAPINE — Original Application (Breckenridge Pharmaceutical, Inc.)
FDA approved a generic version of asenapine (asenapine maleate) from Breckenridge Pharmaceutical, Inc. via an Original Application (ANDA2059…
-
FDA approval · 2021-03-01FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Original Application (ANI Pharmaceuticals, Inc.)
The FDA approved the original application for fluphenazine hydrochloride as a generic product, submitted by ANI Pharmaceuticals, Inc.
-
FDA approval · 2021-02-18FDA Approved: CLOZAPINE — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for Clozapine from Accord Healthcare Inc., resulting in labeling changes for the drug.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-02-18FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)
FDA approved a supplemental application for Clozaril (clozapine) submitted by HLS Therapeutics (USA), Inc.
-
FDA approval · 2021-02-18FDA Approved: VERSACLOZ — Supplemental Application (TruPharma LLC)
FDA approved a supplemental application for Versacloz (clozapine) submitted by TruPharma LLC.
-
FDA approval · 2021-02-18FDA Approved: CLOZAPINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Clozapine filed by Teva Pharmaceuticals USA, Inc. The approval indicates an update to the Cl…
-
FDA approval · 2021-02-18FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Clozapine by Mylan Pharmaceuticals Inc.
-
FDA approval · 2021-02-18FDA Approved: CLOZAPINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application from Aurobindo Pharma Limited for clozapine, allowing the generic product to be marketed.
-
FDA approval · 2021-02-12FDA Approved: RISPERIDONE — Supplemental Application (Janssen Pharmaceutical, Inc.)
The FDA approved Janssen's supplemental application for risperidone, resulting in changes to its labeling/indications.
-
FDA approval · 2021-02-12FDA Approved: INVEGA SUSTENNA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for INVEGA SUSTENNA (paliperidone palmitate) submitted by Janssen Pharmaceuticals, Inc.
-
FDA approval · 2021-02-12FDA Approved: INVEGA HAFYERA — Supplemental Application (Janssen Pharmaceuticals, Inc)
The FDA approved a supplemental application for INVEGA HAFYERA (paliperidone palmitate) from Janssen Pharmaceuticals, Inc.
-
FDA approval · 2021-02-01FDA Approved: ARIPIPRAZOLE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for ARIPIPRAZOLE from Alembic Pharmaceuticals Inc., authorizing a generic aripiprazole product. The …
-
FDA approval · 2021-02-01FDA Approved: ARIPIPRAZOLE — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA approves Dr. Reddy's Laboratories' supplemental application to add a generic aripiprazole orally disintegrating tablet.
-
FDA approval · 2021-01-22FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Original Application (Lannett Company, Inc.)
FDA approved Lannett's generic chlorpromazine hydrochloride (ANDA 212996), authorizing the marketing of a generic chlorpromazine hydrochlori…
-
FDA approval · 2021-01-13FDA Approved: ZYPREXA RELPREVV — Supplemental Application (H2-Pharma LLC)
The FDA approved a supplemental application for ZYPREXA RELPREVV (OLANZAPINE PAMOATE) submitted by H2-Pharma LLC.
-
FDA approval · 2021-01-07FDA Approved: RISPERDAL CONSTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Risperdal Consta (risperidone long-acting injectable) submitted by Janssen Pharmaceuticals, …
-
FDA approval · 2021-01-07FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Original Application (Dr. Reddys Laboratories Inc.)
FDA approved a generic version of fluphenazine hydrochloride under an Original Application for Dr. Reddy's Laboratories Inc.
-
FDA approval · 2020-12-31FDA Approved: OLANZAPINE — Original Application (Hisun Pharmaceuticals USA, Inc.)
FDA approved a generic olanzapine product under Hisun Pharmaceuticals USA, Inc.'s Original Application for olanzapine.
-
FDA approval · 2020-12-31FDA Approved: OLANZAPINE — Original Application (Hisun Pharmaceuticals USA, Inc.)
FDA approved the original abbreviated new drug application for olanzapine, a generic form manufactured by Hisun Pharmaceuticals USA, for use…
-
FDA approval · 2020-12-10FDA Approved: ASENAPINE — Original Application (Alembic Pharmaceuticals Limited)
The FDA approved Alembic Pharmaceuticals Limited's original ANDA for asenapine, enabling a generic version of the drug to be marketed.
-
FDA approval · 2020-12-10FDA Approved: ASENAPINE — Original Application (Sigmapharm Laboratories, LLC)
FDA approved Sigmapharm Laboratories, LLC's original (ANDA) application for asenapine, enabling a generic version to enter the market. The a…
-
FDA approval · 2020-12-10FDA Approved: ASENAPINE — Original Application (Breckenridge Pharmaceutical, Inc.)
FDA approved Breckenridge Pharmaceutical's original application for a generic asenapine maleate product. The generic is intended for the sam…
-
FDA approval · 2020-11-17FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Patriot Pharmaceuticals LLC)
The FDA approved a supplemental application for HALOPERIDOL DECANOATE by Patriot Pharmaceuticals LLC, indicating an approved change to the p…